4:06 PM ET
8-K
Business Update
Scienture Holdings Business Update
Scienture Holdings announced preliminary Q3 2026 revenue of approximately $1.22 million, a 256% sequential increase driven by the launch of REZENOPY and growth in Arbli sales. The company also reported regaining compliance with Nasdaq's minimum bid price requirement after its stock closed above $1.00 for ten consecutive trading days.